Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1590)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (51)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (54)
¹ÙÀÌ¿ÀÀåºñ (357)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (131)
À¯ÀüÀÚ Ä¡·á/RNAi (101)
Àç»ýÀÇÇÐ (124)
Ç×ü/¸é¿ª (191)
½ÃÀ庸°í¼­

European Biomarker Analysis Market

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2009³â 09¿ù »óǰÄÚµå 100966
ÆäÀÌÁö Á¤º¸ 107 Pages
°¡°Ý
US $ 6,500 £Ü 7,744,700 Web Access (Regional License)
US $ 7,000 £Ü 8,340,500 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

This research service gives a detailed analysis of the biomarker analysis market in Europe from 2005-2015.

Table of Contents

1. EXECUTIVE SUMMARY

Overview of the European Biomarker Analysis Market

  • 1. Executive Summary of the European Biomarker Analysis Market

2. EXCHANGE RATES AND GLOSSARY OF TERMS

Glossary of Terms and Exchange Rates

  • 1. Definitions
  • 2. Exchange Rates

3. INDUSTRY CHALLENGES

Challenges Faced by the European Biomarker Analysis Industry

  • 1. Industry Challenges for the European Biomarker Analysis Market

4. TOTAL EUROPEAN BIOMARKER ANALYSIS MARKET

Total Biomarker Analysis Market - Europe

  • 1. Multi-parametric analysis of Companies in the Biomarker Space
  • 2. Introduction
  • 3. Market Overview
  • 4. Scope of the Research
  • 5. Research Methodology
  • 6. Measurements
  • 7. Stakeholder Implications
  • 8. Market Drivers
  • 9. Market Restraints
  • 10. Revenue Forecasts
  • 11. Competitive Structure
  • 12. Global Biomarker Initiatives: Present and Future Directions
  • 13. Analysis of Biomarker Thrust Areas by Disease
  • 14. Key Alliances in the Biomarker Space

Competitive analysis of Biomarker Companies

  • 1. Analysis of Opportunities and Market Attractiveness by Segment
  • 2. Bioinformatics Companies in the Biomarkers Market
  • 3. Assessment of the Theranostics Ambit
  • 4. Analysis of Market Opportunities for CROs in the Biomarkers Market
  • 5. Analysis of Market Attractiveness by Geographical Region

5. MARKET ENGINEERING STRATEGIC RECOMMENDATIONS

Strategic Recommendations

  • 1. Strategic Recommendations for the European Biomarker Analysis Market

6. DATABASE OF KEY INDUSTRY PARTICIPANTS

Key Industry Participants

  • 1. List of Key Industry Participants

7. DECISION SUPPORT DATABASE

Decision Support Databases for the European Biomarker Analysis Market

  • 1. Government Healthcare Expenditure
  • 2. Pharmaceutical R&D Expenditure
  • 3. Per cent Pharmaceutical R&D Expenditure
  • 4. Government Biotechnology R&D Expenditure
  • 5. Private Healthcare Expenditure
Back to Top